An Open-Label Study to Evaluate Biomarkers and Safety in Systemic Sclerosis Patients Treated With ABR-215757 (Paquinimod)
Clinical trial NCT01487551 · COMPLETED
Trial details
- NCT number
- NCT01487551
- Sponsor
- Active Biotech AB
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-01
- Primary completion
- 2013-02-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.